Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain
- PMID: 15380359
- DOI: 10.1016/j.virol.2004.06.041
Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain
Abstract
We investigated the effect of the conserved tyrosine-based endocytosis motif (YXXPhi) in the cytoplasmic domain of the human immunodeficiency viruses (HIV) envelope protein (Env) on its immunogenicity. Genes with codons optimized for mammalian expression were synthesized for the HIV 89.6 Env with a truncated cytoplasmic domain and a mutant Env in which the tyrosine residue in the YXXPhi motif was changed into a serine. Mutation of the Tyr residue enhanced surface expression of the Env protein. Analysis of immune responses induced by DNA immunization of mice showed that the DNA construct for the Tyr mutant Env induced moderately higher levels of T cell responses. More interestingly, the DNA construct for the mutant Env induced significantly higher levels of antibody responses against the Env protein in comparison to the construct for the wild type Env. Our results suggest that the YXXPhi motif in the HIV Env cytoplasmic domain may play a role in virus evasion of host immune responses through affecting its immunogenicity.
Copyright 2004 Elsevier Inc.
Similar articles
-
Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.J Virol. 2004 Dec;78(24):13409-19. doi: 10.1128/JVI.78.24.13409-13419.2004. J Virol. 2004. PMID: 15564451 Free PMC article.
-
Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.Virology. 2006 Aug 15;352(1):74-85. doi: 10.1016/j.virol.2006.04.012. Epub 2006 May 24. Virology. 2006. PMID: 16725170
-
DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice.Vaccine. 2006 Mar 20;24(13):2324-32. doi: 10.1016/j.vaccine.2005.11.063. Epub 2005 Dec 19. Vaccine. 2006. PMID: 16406147
-
Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.Clin Immunol. 2006 Apr;119(1):32-7. doi: 10.1016/j.clim.2005.12.007. Epub 2006 Feb 2. Clin Immunol. 2006. PMID: 16458074
-
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.Vaccine. 2007 Mar 1;25(11):2145-54. doi: 10.1016/j.vaccine.2006.10.057. Epub 2006 Nov 13. Vaccine. 2007. PMID: 17254672
Cited by
-
Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses.J Biomed Biotechnol. 2010;2010:497219. doi: 10.1155/2010/497219. Epub 2010 May 25. J Biomed Biotechnol. 2010. PMID: 20508832 Free PMC article.
-
Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.PLoS One. 2013 Oct 1;8(10):e78521. doi: 10.1371/journal.pone.0078521. eCollection 2013. PLoS One. 2013. Retraction in: PLoS One. 2020 Dec 14;15(12):e0244046. doi: 10.1371/journal.pone.0244046 PMID: 24098600 Free PMC article. Retracted.
-
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.J Virol. 2005 Jul;79(14):8812-27. doi: 10.1128/JVI.79.14.8812-8827.2005. J Virol. 2005. PMID: 15994775 Free PMC article.
-
Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.PLoS One. 2011;6(5):e14813. doi: 10.1371/journal.pone.0014813. Epub 2011 May 19. PLoS One. 2011. PMID: 21625584 Free PMC article.
-
Pseudorabies virus glycoprotein gD contains a functional endocytosis motif that acts in concert with an endocytosis motif in gB to drive internalization of antibody-antigen complexes from the surface of infected monocytes.J Virol. 2005 Jun;79(11):7248-54. doi: 10.1128/JVI.79.11.7248-7254.2005. J Virol. 2005. PMID: 15890963 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical